Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enanta Pharmaceuticals (ENTA) Change in Cash: 2011-2025

Historic Change in Cash for Enanta Pharmaceuticals (ENTA) over the last 15 years, with Sep 2025 value amounting to -$5.5 million.

  • Enanta Pharmaceuticals' Change in Cash fell 958.30% to -$12.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.5 million, marking a year-over-year increase of 88.49%. This contributed to the annual value of -$5.5 million for FY2025, which is 88.49% up from last year.
  • According to the latest figures from FY2025, Enanta Pharmaceuticals' Change in Cash is -$5.5 million, which was up 88.49% from -$48.2 million recorded in FY2024.
  • Enanta Pharmaceuticals' 5-year Change in Cash high stood at $41.4 million for FY2023, and its period low was -$48.2 million during FY2024.
  • Its 3-year average for Change in Cash is -$4.1 million, with a median of -$5.5 million in 2025.
  • In the last 5 years, Enanta Pharmaceuticals' Change in Cash spiked by 520.16% in 2023 and then tumbled by 216.33% in 2024.
  • Yearly analysis of 5 years shows Enanta Pharmaceuticals' Change in Cash stood at -$29.9 million in 2021, then surged by 67.08% to -$9.9 million in 2022, then soared by 520.16% to $41.4 million in 2023, then tumbled by 216.33% to -$48.2 million in 2024, then surged by 88.49% to -$5.5 million in 2025.